Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Nov 24;9(1):133-136.
doi: 10.1002/ccr3.3482. eCollection 2021 Jan.

Unusual clinical presentation of cutaneous leishmaniasis in a patient with corticosteroid-induced immunosuppression

Maryam Mahdavi  1 , Reihaneh Aryan  1 , Yalda Nahidi  1 , Mehrdad Teimoorian  2 , Vahid Mashayekhi  1
Affiliations
Case Reports

Unusual clinical presentation of cutaneous leishmaniasis in a patient with corticosteroid-induced immunosuppression

Maryam Mahdavi et al. Clin Case Rep. .

Abstract

Clinicians should always consider rare, atypical, and opportunistic infections in patients undergoing long-term systemic corticosteroid therapy. Diagnosis needs further evaluations and special consideration.

Keywords: cutaneous leishmaniasis; disseminated; immunosuppression; recurrence; systemic corticosteroids.

PubMed Disclaimer

Conflict of interest statement

None declared.

Figures

FIGURE 1
FIGURE 1
Erythematous and indurated lesions with thick hyperkeratotic crusts before treatment (A) and after 28 d of treatment with glucantime (B)
FIGURE 2
FIGURE 2
Cutaneous lesions on patient's torso before treatment (C) and after 28 d of treatment with glucantime (D)
FIGURE 3
FIGURE 3
Hematoxylin and eosin stain showing dense lymphohistiocytic infiltrates in dermal layer and histiocytes with foamy cytoplasm and numerous leishman bodies
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Pace D. Leishmaniasis. J Infect. 2014;69(1):10‐18. - PubMed
    1. Firooz A, Mortazavi H, Khamesipour A, et al. Old World cutaneous leishmaniasis in Iran: clinical variants and treatments. J Dermatolog Treat. 2020;8:1‐11. - PubMed
    1. Van Griensven J, Carrillo E, Lopez‐Velez R, Lynen L, Moreno J. Leishmaniasis in immunosuppressed individuals. Clin Microbiol Infect. 2014;20(4):286‐299. - PubMed
    1. Liese J, Schleicher U, Bogdan C. The innate immune response against Leishmania parasites. Immunobiology. 2008;213(3‐4):377‐387. - PubMed
    1. Youssef J, Novosad SA, Winthrop KL. Infection risk and safety of corticosteroid use. Rheum Dis Clin North Am. 2016;42(1):157‐176. 10.1016/j.rdc.2015.08.004 - DOI - PMC - PubMed

Publication types

LinkOut - more resources